Learn about Leqembi, Saudi Arabia's first approved treatment for Alzheimer’s disease, marking a major advancement in ...

Mumbai faces a rising threat of neurocysticercosis due to monsoon floods, warn doctors. The brain infection, caused by pork ...

Investing.com -- Hyperfine, Inc. (NASDAQ: HYPR) stock climbed 4.6% following the announcement of promising early results from its CARE PMR study presented at the 2025 Alzheimer’s Association ...

Kisunla’s active substance is donanemab, a monoclonal antibody that targets and clears amyloid-beta plaques in the brain, a ...

Because the early symptoms of brain abscesses resemble migraines, flu, or neck pain, many patients dismiss them or rely on ...

The symptoms of neurocysticercosis will differ in severity, depending on the amount, size and location of the cysts in the ...

Making Everything Good, a nonprofit that supports and provides assistance to first responders, military personnel, veterans ...

Trontinemab is one of a class of new medicines aimed at clearing amyloid plaques. The new findings from phase two trials ...

A NEW “game-changing” drug could stop the progression of Alzheimer’s disease, early trials suggest. Scientists say the ...

Discover the facts about CLOVES syndrome—an extremely rare genetic disorder with complex symptoms and challenging diagnosis.

Therini Bio, Inc., a clinical-stage biotech company developing fibrin-targeting immunotherapies for neurodegenerative diseases driven by vascular dysfunction today announced that the first patient has ...

Ravens coaches rave about rookie defensive back Reuben Lowery. Could the FCS product become an unlikely member of the 53-man ...